AAAAAA

   
Results: 1-11 |
Results: 11

Authors: SCHWARTSMANN G HOROWITZ M DILEONE L SANDER E CAMPOS O FERREIRA AF SCHUNEMANN H VIEGAS MAV CANCELA AI MANS DRA
Citation: G. Schwartsmann et al., PHASE-I TRIAL OF THE BOMBESIN RECEPTOR ANTAGONIST RC-3095 IN PATIENTSWITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 651-651

Authors: SCHWARTSMANN G DILEONE L CALDAS APF CAMPOS O CANCELA AI VIEGAS MAV MANS DRA
Citation: G. Schwartsmann et al., PHASE-I AND PHARMACOKINETIC STUDY OF LOW-DOSE, 3-TIMES DAILY ORAL ETOPOSIDE IN PATIENTS WITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 660-660

Authors: LERNER CB SCHAPOVAL E MOTHES B HENRIQUES AT SCHWARTSMANN G MANS DRA
Citation: Cb. Lerner et al., ANTICANCER SCREENING OF SOUTH BRAZILIAN MARINE SPONGES, Annals of oncology, 9, 1998, pp. 133-133

Authors: MONDIN C VONPOSER G MANS DRA FERRAZ A DIEL CL DELIMA C LOPES RM BARROS M DAROCHA AB VARELLA D CRAGG G SCHWARTSMANN G
Citation: C. Mondin et al., TARGETED PLANT COLLECTION AS A RATIONAL MEANS TO ACQUIRE CANDIDATE ANTICANCER COMPOUNDS FOR SCREENING, Annals of oncology, 9, 1998, pp. 134-134

Authors: SCHWARTSMANN G MANS DRA DILEONE L CALDAS APF CAMPOS O SANDER E BORTOLINI M VIEGAS MAV CANCELA AI
Citation: G. Schwartsmann et al., PHASE-I AND PHARMACOKINETIC STUDY OF ORAL ETOPOSIDE GIVEN 3-TIMES DAILY ORALLY TO PATIENTS WITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 252-252

Authors: DAROCHA AB MANS DRA FONESCA VM RUSCHEL C SCHWARTSMANN G
Citation: Ab. Darocha et al., EFFECTS OF ORNITHINE DECARBOXYLASE (ODC) INHIBITION USING D,I-ALPHA-DIFLUOROMETHYLORNITHINE (DFMO), ON THE IN-VITRO INVASIVENESS OF CULTURED HUMAN GLIOBLASTOMA CELLS, Annals of oncology, 9, 1998, pp. 274-274

Authors: SCHWARTSMANN G HOROWITZ M DILEONE L SANDER E CAMPOS O FERREIRA AF SCHUNEMANN H VIEGAS MAV CANCELA AI MANS DRA
Citation: G. Schwartsmann et al., PHASE-I TRIAL OF THE BOMBESIN RECEPTOR ANTAGONIST RC-3095 IN PATIENTSWITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 420-420

Authors: MANS DRA DAROCHA AB RUSCHEL C FONSECA VM BRAGA A SCHWARTSMANN G
Citation: Dra. Mans et al., RADIOSENSITIZATION OF CULTURED HUMAN GLIOBLASTOMA CELLS THROUGH INHIBITION OF PROTEIN-KINASE-C ACTIVITY, Annals of oncology, 9, 1998, pp. 521-521

Authors: SCHWARTSMANN G SPRINZ E KROMFIELD M KALAKUN L SANDER E PROLLA G DILEONE L GERHARDT L MANS DRA
Citation: G. Schwartsmann et al., CLINICAL AND PHARMACOKINETIC STUDY OF ORAL ETOPOSIDE IN PATIENTS WITHAIDS-RELATED KAPOSIS-SARCOMA WITH NO PRIOR EXPOSURE TO CYTOTOXIC THERAPY, Journal of clinical oncology, 15(5), 1997, pp. 2118-2124

Authors: SCHWARTSMANN G SPRINZ E KALAKUN L YAMAGUSHI N SANDER E GRIVICICH I KOYA R MANS DRA
Citation: G. Schwartsmann et al., PHASE-II STUDY OF PENTOSAN POLYSULFATE (PPS) IN PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA, Tumori, 82(4), 1996, pp. 360-363

Authors: MANS DRA SCALETZKY A BECKER D DEOLIVEIRA JR PINHEIRO CM BITTAR C FERREIRA AF MACHADO VL RITT JL JUNG FA LEYVA A SCHWARTSMANN G
Citation: Dra. Mans et al., 2 NEW CASES OF HYPERPYRIMIDINURIA ASSOCIATED WITH EXCESSIVE 5-FLUOROURACIL TOXICITY, Annals of oncology, 5(8), 1994, pp. 772-773
Risultati: 1-11 |